Raymond James Financial Services Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-30,543
| Closed | -$729K | – | 2899 |
|
|
2019
Q4 | $729K | Sell |
30,543
-925
| -3% | -$22.1K | ﹤0.01% | 1731 |
|
|
2019
Q3 | $844K | Sell |
31,468
-1,707
| -5% | -$45.8K | ﹤0.01% | 1573 |
|
|
2019
Q2 | $900K | Buy |
33,175
+23,995
| +261% | +$651K | ﹤0.01% | 1564 |
|
|
2019
Q1 | $319K | Buy |
+9,180
| New | +$319K | ﹤0.01% | 2197 |
|
|
2018
Q4 | – | Sell |
-8,041
| Closed | -$214K | – | 2882 |
|
|
2018
Q3 | $214K | Sell |
8,041
-820
| -9% | -$21.8K | ﹤0.01% | 2489 |
|
|
2018
Q2 | $335K | Sell |
8,861
-230
| -3% | -$8.7K | ﹤0.01% | 2161 |
|
|
2018
Q1 | $297K | Buy |
9,091
+739
| +9% | +$24.1K | ﹤0.01% | 2034 |
|
|
2017
Q4 | $407K | Buy |
8,352
+900
| +12% | +$43.9K | ﹤0.01% | 1829 |
|
|
2017
Q3 | $403K | Buy |
7,452
+3,044
| +69% | +$165K | ﹤0.01% | 1838 |
|
|
2017
Q2 | $248K | Buy |
+4,408
| New | +$248K | ﹤0.01% | 2078 |
|